2Belgian Isepamicin Muhicenter Study Group. Comparative in vitro activity of isepamicin and other antibiotics against gram-negative bacilli from intensive care units (ICU) in Belgium. Acta Clinbelg, 2001,56(5) :307 315. 被引量：1
3Tod M. Clinical Pharmacokinetics and pharmacodynamics of isepamicin. Clin-pharmacokinet ,2000,38 (3) :205. 被引量：1
4Tod M. Isepamicin in intensive care unit patients with nosocomial pneumonia: population pharmacokinetic-pharmacodynamic study. J Antimicrob Chemother,2004 ,44 :99-108. 被引量：1
5Zarrilli R,GiarmouliM, Tomasone F,et al. Carbapenem resistance in Acinetobacter baumanii the molecular epidemic features of an emerging problem in health care facilities. J Infect Dev Ctries, 2009,3(5):335-341. 被引量：1
6Belgian Isepamicin Multicenter Study Group. Comparative in vitro activity of isepamicin and other antibofics against gram-negafve bacilli from intensive care units(ICU) in Belgium. Acta Clin Belg, 20{31, 56(5): 307-315. 被引量：1
8Rea-Neto A, Youssef NC, Tuchel F, et al.Diagnosis of ventilator-associated pneumonia:a systematic review of the literature[J].Crit Care, 2008, 12 (2) : R56. 被引量：1
9Khilnani GC, Arafath TK, Hadda V, et al. Comparison of bron-choscopic and non-bronchoscopic techniques for diagnosis of ventilator associated pneumonia[J].Indian J CritCareMed, 2011, 15 (1) : 16-23. 被引量：1
10Canadian Critical Care Trials Group.A randomized trial of diagnostic techniques for ventilator-associated pneumonia[J].N Eng. J Med, 2006, 355 (25) : 2619- 2630. 被引量：1
